• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 - 2019年作为数字健康领域风险投资投资者的卫生系统

Health systems as venture capital investors in digital health: 2011-2019.

作者信息

Safavi Kyan C, Cohen Adam B, Ting David Y, Chaguturu Sreekanth, Rowe Jack S

机构信息

Massachusetts General Physicians Organization, Boston, MA USA.

Harvard Medical School, Boston, MA USA.

出版信息

NPJ Digit Med. 2020 Aug 4;3:103. doi: 10.1038/s41746-020-00311-5. eCollection 2020.

DOI:10.1038/s41746-020-00311-5
PMID:32802968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403411/
Abstract

Provider health systems as venture capital investors in digital health are uniquely positioned in the industry. Little is known about the volume or characteristics of their investments and how these compare to other investors. From 2011 to 2019, we found that health systems made 184 investments in 105 companies. Compared with other investors, they were more likely to invest in companies focused on workflow, on-demand health services, and data infrastructure/interoperability.

摘要

作为数字健康领域风险投资投资者的医疗服务提供方医疗系统在该行业中具有独特地位。关于其投资规模、特点以及与其他投资者的比较情况,我们知之甚少。在2011年至2019年期间,我们发现医疗系统对105家公司进行了184笔投资。与其他投资者相比,它们更有可能投资于专注于工作流程、按需医疗服务以及数据基础设施/互操作性的公司。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8794/7403411/7ad81cc923dd/41746_2020_311_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8794/7403411/ba06dcec171e/41746_2020_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8794/7403411/7ad81cc923dd/41746_2020_311_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8794/7403411/ba06dcec171e/41746_2020_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8794/7403411/7ad81cc923dd/41746_2020_311_Fig2_HTML.jpg

相似文献

1
Health systems as venture capital investors in digital health: 2011-2019.2011 - 2019年作为数字健康领域风险投资投资者的卫生系统
NPJ Digit Med. 2020 Aug 4;3:103. doi: 10.1038/s41746-020-00311-5. eCollection 2020.
2
Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.组织工程/再生医学产品商业化中的障碍:政府资助机构和金融行业的试点调查。
Tissue Eng Part A. 2012 Nov;18(21-22):2187-94. doi: 10.1089/ten.TEA.2012.0186. Epub 2012 Sep 27.
3
How venture capital works.风险投资的运作方式。
Harv Bus Rev. 1998 Nov-Dec;76(6):131-9.
4
Venture capital investment in urology, 2011 to mid-2021.2011 年至 2021 年中期的泌尿科风险投资。
Can J Urol. 2023 Oct;30(5):11659-11667.
5
Private equity investment in health care services.私募股权投资医疗服务业。
Health Aff (Millwood). 2008 Sep-Oct;27(5):1389-98. doi: 10.1377/hlthaff.27.5.1389.
6
Towards a 'wide' role for venture capital in OECD countries' industry 4.0.论风险投资在经合组织国家工业4.0中的“广泛”作用。
Heliyon. 2022 Jan 3;8(1):e08700. doi: 10.1016/j.heliyon.2021.e08700. eCollection 2022 Jan.
7
Venture Capital Investment in the Life Sciences in Switzerland.瑞士生命科学领域的风险投资
Chimia (Aarau). 2014 Dec;68(12):847-9. doi: 10.2533/chimia.2014.847.
8
Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies.风险投资全子对股票错误定价的影响:来自中国上市公司的证据。
PLoS One. 2023 Apr 13;18(4):e0281255. doi: 10.1371/journal.pone.0281255. eCollection 2023.
9
Is Digital Health for Diabetes in an Investment Bubble?数字医疗在糖尿病领域是否存在投资泡沫?
J Diabetes Sci Technol. 2020 Jan;14(1):165-169. doi: 10.1177/1932296819867742. Epub 2019 Aug 30.
10
Institutional investors and cost of capital: The moderating effect of ownership structure.机构投资者与资本成本:股权结构的调节效应。
PLoS One. 2021 Apr 8;16(4):e0249963. doi: 10.1371/journal.pone.0249963. eCollection 2021.

引用本文的文献

1
Venture Capital's Role in Advancing Plastic Surgery.风险投资在推动整形手术发展中的作用。
Aesthet Surg J Open Forum. 2024 Aug 27;6:ojae064. doi: 10.1093/asjof/ojae064. eCollection 2024.
2
Approaches to Evaluating Digital Health Technologies: Scoping Review.评估数字健康技术的方法:范围综述。
J Med Internet Res. 2024 Aug 28;26:e50251. doi: 10.2196/50251.
3
Impact of COVID-19 on Characteristics and Funding of U.S. Healthcare Startups: Retrospective Review.COVID-19 对美国医疗保健初创企业的特征和资金的影响:回顾性研究。

本文引用的文献

1
Digital health: a path to validation.数字健康:验证之路。
NPJ Digit Med. 2019 May 13;2:38. doi: 10.1038/s41746-019-0111-3. eCollection 2019.
2
Potential Implications of Private Equity Investments in Health Care Delivery.私募股权投资对医疗服务提供的潜在影响。
JAMA. 2019 Mar 19;321(11):1047-1048. doi: 10.1001/jama.2019.1077.
3
Special report: The Transformation Imperative: Hospital-based venture funds bet big on health startups.特别报道:转型势在必行:医院风险投资基金对健康领域初创企业大举押注。
JMIR Form Res. 2024 Aug 27;8:e56327. doi: 10.2196/56327.
4
The Political Economy of Digital Health Equity: Structural Analysis.数字健康公平的政治经济学:结构分析。
J Med Internet Res. 2024 Mar 26;26:e46971. doi: 10.2196/46971.
5
Aligning mission to digital health strategy in academic medical centers.在学术医疗中心将使命与数字健康战略相结合。
NPJ Digit Med. 2022 Jun 2;5(1):67. doi: 10.1038/s41746-022-00608-7.
6
Community Health Programs Delivered Through Information and Communications Technology in High-Income Countries: Scoping Review.高收入国家利用信息通信技术开展的社区卫生规划:范围综述。
J Med Internet Res. 2022 Mar 9;24(3):e26515. doi: 10.2196/26515.
7
From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies.从精准元药理学到患者赋权:利用数字健康技术提供癫痫、疼痛、抑郁症和癌症的自我护理实践
Front Pharmacol. 2021 Apr 23;12:612602. doi: 10.3389/fphar.2021.612602. eCollection 2021.
Mod Healthc. 2017 Apr;47(15):21-23.
4
provider venture capital funds: investing in innovation.医疗服务提供商风险投资基金:投资于创新。
Healthc Financ Manage. 2016 May;70(5):50-9.
5
Fueling innovation in medical devices (and beyond): venture capital in health care.推动医疗设备(及其他领域)的创新:医疗保健领域的风险投资。
Health Aff (Millwood). 2009 Jan-Feb;28(1):w68-75. doi: 10.1377/hlthaff.28.1.w68. Epub 2008 Dec 2.
6
Private equity investment in health care services.私募股权投资医疗服务业。
Health Aff (Millwood). 2008 Sep-Oct;27(5):1389-98. doi: 10.1377/hlthaff.27.5.1389.